Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van der Poll

Showing results (1-10 of 227) with videos related to

Pageof 23
Sort By:
The Lancet. Infectious Diseases|March 2, 2002
Immunotherapy of sepsisT van der Poll
Critical Care Medicine|December 1, 2000
The use of granulocyte colony-stimulating factor in critically ill patientsT van der Poll
Journal of Endotoxin Research|November 22, 2001
Coagulation and inflammationT van der Poll
Minerva Anestesiologica|December 18, 2012
Thrombomodulin in sepsisM Levi, T Van Der Poll
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2005
[Toll-like receptors and the significance for clinical medicine]W J Wiersinga, T van der Poll
Shock (Augusta, Ga.)|January 1, 1995
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?T van der Poll, S F Lowry
Journal of Internal Medicine|November 25, 2014
Endothelial barrier dysfunction in septic shockS M Opal, T van der Poll
Clinical Science (London, England : 1979)|March 1, 1993
Tumour necrosis factor-alpha: its role in the metabolic response to sepsisT van der Poll, H P Sauerwein
Infection and Immunity|June 1, 1997
Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisoneT van der Poll, S F Lowry
The American Journal of Physiology|January 22, 1998
Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10T Van der Poll, S F Lowry
Pageof 23

Showing results (1-10 of 227) with videos related to

Sort By:
Pageof 23
The Lancet. Infectious Diseases|March 2, 2002
Immunotherapy of sepsisT van der Poll
Critical Care Medicine|December 1, 2000
The use of granulocyte colony-stimulating factor in critically ill patientsT van der Poll
Journal of Endotoxin Research|November 22, 2001
Coagulation and inflammationT van der Poll
Minerva Anestesiologica|December 18, 2012
Thrombomodulin in sepsisM Levi, T Van Der Poll
Nederlands Tijdschrift Voor Geneeskunde|June 9, 2005
[Toll-like receptors and the significance for clinical medicine]W J Wiersinga, T van der Poll
Shock (Augusta, Ga.)|January 1, 1995
Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense?T van der Poll, S F Lowry
Journal of Internal Medicine|November 25, 2014
Endothelial barrier dysfunction in septic shockS M Opal, T van der Poll
Clinical Science (London, England : 1979)|March 1, 1993
Tumour necrosis factor-alpha: its role in the metabolic response to sepsisT van der Poll, H P Sauerwein
Infection and Immunity|June 1, 1997
Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisoneT van der Poll, S F Lowry
The American Journal of Physiology|January 22, 1998
Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10T Van der Poll, S F Lowry
Pageof 23